Highbridge Capital Management, LLC filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 11,010,766 shares of Sharplink, Inc. common stock as of September 30, 2026.
Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, reporting beneficial ownership of 654,922 Class A Ordinary Shares of Lake Superior Acquisition Corp as of September 30, 2026.
RTW Investments, LP and Roderick Wong filed Amendment No. 8 to Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 6,537,475 shares of Stoke Therapeutics, Inc. common stock as of September 30, 2026.
Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 1,105,223 Class A Ordinary Shares of Lionheart Holdings as of September 30, 2026.
RTW Investments, LP and its Managing Partner Roderick Wong, M.D. filed Amendment No. 4 to their beneficial ownership statement covering Tenax Therapeutics, Inc. common stock, disclosing a position of zero shares as of September 30, 2026, with the filing submitted on November 16, 2026.
Rafael Holdings, Inc. filed a definitive proxy statement on November 16, 2026, soliciting stockholder votes for its 2027 Annual Meeting of Stockholders scheduled for January 7, 2027, at the company's offices in Newark, New Jersey.
RTW Investments, LP and Roderick Wong filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 103,509,730 ordinary shares of Zai Lab Limited as of September 30, 2026.
AQR Capital Management, LLC, AQR Capital Management Holdings, LLC, and AQR Arbitrage, LLC jointly filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of Class A ordinary shares in AMR Resources Acquisition Corp. as of September 30, 2026.
Accelevation Holdings Corp. filed a Form 8-K/A on November 16, 2026, amending its November 12, 2026 current report to correct two errors in the press release covering financial results for the quarter ended September 30, 2026.
Our Bond, Inc. filed a Form 8-K on November 16, 2026, disclosing that its Board of Directors approved on November 15, 2026, the conversion of Series B Preferred Stock with a total stated value of $13,261,259.92 into 6,532,640 shares of common stock at a …